Harwood works with technology and business leaders to respond to rapid innovation at the intersection of science and technology. His research explores the rise of generative AI and accelerated use of ...

The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

At the foundation is PEAK:AIO's ultra-high performance AI Data Server driving this transformation, delivering real-time ...

Majority of leaders in life sciences -- pharmaceutical and medical technology companies -- and high-tech companies like ...

A strategic partnership with PharmaOverseas to provide digital payment solutions for the pharmaceutical distribution industry ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

AI’s role in healthcare evolved significantly in 2024. Rather than generic AI solutions, startups focused on specialized, ...

(NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of ...